Compare TSLA & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSLA | PFE |
|---|---|---|
| Founded | 2003 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5T | 141.6B |
| IPO Year | 2010 | N/A |
| Metric | TSLA | PFE |
|---|---|---|
| Price | $439.30 | $25.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 31 | 11 |
| Target Price | ★ $397.33 | $27.18 |
| AVG Volume (30 Days) | ★ 66.4M | 43.6M |
| Earning Date | 01-28-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 6.71% |
| EPS Growth | N/A | ★ 131.89 |
| EPS | 1.45 | ★ 1.73 |
| Revenue | ★ $95,633,000,000.00 | $62,785,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.49 | N/A |
| P/E Ratio | $286.48 | ★ $14.91 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $214.25 | $20.92 |
| 52 Week High | $498.83 | $27.69 |
| Indicator | TSLA | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 55.61 |
| Support Level | $434.22 | $24.97 |
| Resistance Level | $454.30 | $25.77 |
| Average True Range (ATR) | 12.34 | 0.44 |
| MACD | -2.54 | 0.06 |
| Stochastic Oscillator | 33.01 | 71.91 |
Tesla is a vertically integrated battery electric vehicle automaker and developer of real world artificial intelligence software, which includes autonomous driving and humanoid robots. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling a sports car and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network and an auto insurance business.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.